HPLC-VALIDATION OF MOXIFLOXACIN

Shahbaz, K; Javed, I

HPLC-VALIDATION OF MOXIFLOXACIN

Shahbaz, K

Javed, I

Permalink

Publisher:: International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL)
Publication Type:: Journal Article
Citation:: International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL), 2016, 5 (3), pp. 2092 - 2098 (6)
Issue Date:: 2016-05-01

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published VersionAdobe PDF (237.82 kB)

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Shahbaz, K https://orcid.org/0000-0002-0030-9716	en_US
dc.contributor.author	Javed, I	en_US
dc.date.issued	2016-05-01	en_US
dc.identifier.citation	International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL), 2016, 5 (3), pp. 2092 - 2098 (6)	en_US
dc.identifier.uri	http://hdl.handle.net/10453/122046
dc.description.abstract	The structure formula of moxifloxacin is described as follows: 8 methoxy flouroquinolone: and it is broad spectrum antibiotic [1, 2].we study moxifloxacin by IV drug delivery system. And for its study following apparatus is used; 1-a reversed-phase Lichrospher RP-18 column, 2-a mobile phase which is composed of different solvents. It is detected at a wavelength of 290 nm. By this method the retention time of moxifloxacin is very short. When we detect it in plasma and brain tissue linear curves are obtained. .The advantage of this method is that we can detect the bacteria in plasma and brain tissues by this method.	en_US
dc.publisher	International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL)	en_US
dc.relation.ispartof	International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL)	en_US
dc.title	HPLC-VALIDATION OF MOXIFLOXACIN	en_US
dc.type	Journal Article
utslib.citation.volume	3	en_US
utslib.citation.volume	5	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Students
utslib.copyright.status	open_access
pubs.consider-herdc	true	en_US
pubs.issue	3	en_US
pubs.publication-status	Published	en_US
pubs.volume	5	en_US

Abstract:

The structure formula of moxifloxacin is described as follows: 8 methoxy flouroquinolone: and it is broad spectrum antibiotic [1, 2].we study moxifloxacin by IV drug delivery system. And for its study following apparatus is used; 1-a reversed-phase Lichrospher RP-18 column, 2-a mobile phase which is composed of different solvents. It is detected at a wavelength of 290 nm. By this method the retention time of moxifloxacin is very short. When we detect it in plasma and brain tissue linear curves are obtained. .The advantage of this method is that we can detect the bacteria in plasma and brain tissues by this method.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/122046